Literature DB >> 11792341

Effect of non-insulin-dependent diabetes mellitus on pulmonary function and exercise tolerance in chronic congestive heart failure.

Marco Guazzi1, Roberto Brambilla, Gianluca Pontone, Piergiuseppe Agostoni, Maurizio D Guazzi.   

Abstract

In chronic congestive heart failure (CHF), backward effects of left ventricular dysfunction alter pulmonary volumes and gas diffusion. Some of these disorders are detected in some patients with diabetes mellitus, possibly due to a microangiopathic process and nonenzymatic glycosylation of lung tissue proteins. We explored the possibility that coexistence of non-insulin-dependent diabetes mellitus (NIDDM) may potentiate the deterioration of lung function in CHF. In 20 normoglycemic patients (group 1) and in 20 patients with NIDDM (group 2), with New York Heart Association class II to III CHF due to idiopathic or ischemic cardiac disease, and in 20 controls (groups were age- and gender-matched), we investigated cardiac function, pulmonary volumes, carbon monoxide diffusion (DL(CO)) and its alveolar-capillary membrane (D(M)) subcomponent, oxygen uptake and dead space-to-tidal volume ratio (pVD/VT) at peak exercise (individualized ramp test), and slope of ventilation-to-carbon dioxide production ratio (VE/VCO(2)) during exercise. Although, compared with reference subjects, both patient groups had similar variations in left ventricular diastolic volume, ejection fraction, and pulmonary wedge pressure; in group 2 lung volumes, DL(CO), D(M), and oxygen uptake were significantly more reduced; in this group there was no overlap of individual results of DL(CO) and D(M) with those in controls; VE/VCO(2) slope and pVD/VT also were significantly increased, and inversely correlated with D(M). Thus, coexistence of NIDDM makes pulmonary dysfunction worse in CHF, and significantly enhances exercise intolerance.

Entities:  

Mesh:

Year:  2002        PMID: 11792341     DOI: 10.1016/s0002-9149(01)02199-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Association of antidiabetic medications targeting the glucagon-like peptide 1 pathway and heart failure events in patients with diabetes.

Authors:  Mauricio Velez; Edward L Peterson; Karen Wells; Tanmay Swadia; Hani N Sabbah; L Keoki Williams; David E Lanfear
Journal:  J Card Fail       Date:  2014-10-28       Impact factor: 5.712

2.  Fatty diabetic lung: functional impairment in a model of metabolic syndrome.

Authors:  Cuneyt Yilmaz; Priya Ravikumar; Dennis J Bellotto; Roger H Unger; Connie C W Hsia
Journal:  J Appl Physiol (1985)       Date:  2010-08-26

Review 3.  Animal models of insulin resistance and heart failure.

Authors:  Mauricio Velez; Smita Kohli; Hani N Sabbah
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

4.  Aquatic exercise is effective in improving exercise performance in patients with heart failure and type 2 diabetes mellitus.

Authors:  Cider Asa; Schaufelberger Maria; Stibrant Sunnerhagen Katharina; Andersson Bert
Journal:  Evid Based Complement Alternat Med       Date:  2012-04-23       Impact factor: 2.629

5.  Restrictive pattern on spirometry: association with cardiovascular risk and level of physical activity in asymptomatic adults.

Authors:  Evandro Fornias Sperandio; Rodolfo Leite Arantes; Agatha Caveda Matheus; Rodrigo Pereira da Silva; Vinícius Tonon Lauria; Marcello Romiti; Antônio Ricardo de Toledo Gagliardi; Victor Zuniga Dourado
Journal:  J Bras Pneumol       Date:  2016 Jan-Feb       Impact factor: 2.624

6.  Impaired lung function is associated with increased carotid intima-media thickness in middle-aged and elderly Chinese.

Authors:  Zhimin Ma; Yu Liu; Yu Xu; Yun Huang; Min Xu; Xiaolin Zhu; Huijie Zhang; Baihui Xu; Fei Huang; Zhi Yang; Xiaoying Li; Weiqing Wang; Yufang Bi
Journal:  PLoS One       Date:  2013-02-15       Impact factor: 3.240

Review 7.  Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction.

Authors:  Rohan Samson; Abhishek Jaiswal; Pierre V Ennezat; Mark Cassidy; Thierry H Le Jemtel
Journal:  J Am Heart Assoc       Date:  2016-01-25       Impact factor: 5.501

8.  Chronic heart failure with diabetes mellitus is characterized by a severe skeletal muscle pathology.

Authors:  Jack O Garnham; Lee D Roberts; Ever Espino-Gonzalez; Anna Whitehead; Peter P Swoboda; Aaron Koshy; John Gierula; Maria F Paton; Richard M Cubbon; Mark T Kearney; Stuart Egginton; T Scott Bowen; Klaus K Witte
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-12-21       Impact factor: 12.910

9.  Type 2 diabetes is an independent predictor of lowered peak aerobic capacity in heart failure patients with non-reduced or reduced left ventricular ejection fraction.

Authors:  Takahiro Abe; Takashi Yokota; Arata Fukushima; Naoya Kakutani; Takashi Katayama; Ryosuke Shirakawa; Satoshi Maekawa; Hideo Nambu; Yoshikuni Obata; Katsuma Yamanashi; Ippei Nakano; Shingo Takada; Isao Yokota; Koichi Okita; Shintaro Kinugawa; Toshihisa Anzai
Journal:  Cardiovasc Diabetol       Date:  2020-09-19       Impact factor: 9.951

Review 10.  Skeletal muscle atrophy in heart failure with diabetes: from molecular mechanisms to clinical evidence.

Authors:  Nathanael Wood; Sam Straw; Mattia Scalabrin; Lee D Roberts; Klaus K Witte; Thomas Scott Bowen
Journal:  ESC Heart Fail       Date:  2020-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.